1105601 UiO Life Sciences user equipment. K936.03 Cell Work

Who already wins at this buyer

Firms with recorded awards from STATSBYGG in this tender’s CPV categories — the incumbents you are bidding against.

Full buyer profile: what STATSBYGG buys and who wins it →

CPV codes

Description

Statsbygg is building the new Life Sciences Building (LVB) for the University of Oslo and Oslo University Hospital on behalf of the Ministry of Education and Research and the South-Eastern Region as co-contractors. The building will be a workplace for approximately 1,600 employees and 1,600 students. The excavation and groundwork started in the second quarter of 2019 and is scheduled for completion by the end of 2026. Here, various academic communities will work interdisciplinary to develop new solutions to major challenges in health and sustainability with access to the best and most modern equipment required to conduct world-class research, teaching and innovation. STEMvisionStatsbygg intends to enter a contract without prior announcement with StemCell technologies for the acquisition of a STEMvision, an instrument to perform standardised scoring and automated colony counting for hematopoietic progenitor colony-forming unit (CFU) assays, and a Robosep-S, a fully automated cell extractor that uses immunomagnetic technology to isolate cells. STEMvision: the research group regularly performs hematopoietic colony-forming unit (CFU) assays to study human stem and progenitor cell functions. Through professional expertise in the laboratory, as well as research done online, we find that STEMvision is the only system with the following characteristics:A bench-top fully automated imaging and colony counting system designed specifically for automatic hematopoietic progenitor cell (HPC) colony-forming unit (CFU) assays with automated digital image capture and specialised analysis software to analyse and classify complex blood stem cell colonies. STEMvision does the complete analysis automatically in 1-2 minutes per sample, with a permanent record of the analysis. Appendix 4.0 – Requirements K936.03.01 provides a complete list of all absolute requirements. To obtain the appendix, please submit a request to tom.ask@nosyko.no.RoboSep-SRoboSep-S: The research group works with primary cells, mainly of human origin, freshly isolated. Through professional expertise in the laboratory, as well as research done online, we find that RoboSep-S is the only system with the following characteristics:A fully automated tabletop cell extractor that performs simultaneous cell isolations for up to 4 samples using the same (i.e. the same protocol applied for up to 4 different samples) or different protocols. Fully automated sequential isolation of up to 4 cell types - sequential isolation means that more than one cell type can be isolated from the same starting sample without any manual action between the fractions. Column-free and tubing free isolation using 4 magnets that support both positive and negative selection of target cells. Appendix 4.0 – Requirements K936.03.02 provides a complete list of all absolute requirements. To obtain the appendix, please submit a request to tom.ask@nosyko.no.Summary:Based on our technical requirements and needs, as outlined in the requirement specifications, as well as the available information and the investigations conducted, it is our assessment that only StemCell Technologies meets these requirements. For technical reasons, they are therefore the sole provider capable of delivering the service. The conditions set out in FOA § 13-4 (b) are considered to be fulfilled. Any objections must be submitted by e-mail to kristine.milner.carlsen@statsbygg.no within 10 days of the publication of this notice

Similar tenders

Closest by meaning — across languages, via embeddings.

Source

View the official notice on TED ↗